文献速递血管炎

基于集成聚类的ANCA相关性血管炎临床表型:两项日本队列的预后与治疗启示

Clinical phenotypes of ANCA-associated vasculitis using ensemble clustering: prognostic and therapeutic insights from two Japanese cohorts.
PubMed 文献 · Rheumatology (Oxford) · 2026-01-01

该多中心回顾性队列研究利用日本两个全国性登记库(J-CANVAS为推导队列,JPVAS为验证队列),对726例新诊断MPA或GPA患者进行基于器官受累的高维数据集成聚类,识别出四种可重复的临床表型,并发现各表型在总生存、复发及诱导治疗反应上存在差异。

要点

  • 集成聚类识别出四种可重复AAV表型:无ILD的肾脏主导型、伴ILD的肾脏主导型、全身多器官型和ENT主导型。
  • ENT主导型生存较好但复发风险较高,利妥昔单抗较CYC显示改善无复发生存的趋势。
  • 将表型模式与ANCA血清型整合可能增强风险分层并支持个体化管理。

核心结论

  • 基于器官受累的集成聚类可识别具有 distinct 预后和治疗特征的、临床有意义且可重复的AAV表型。
  • 将表型模式与ANCA血清型整合可能增强风险分层并支持更个体化的管理策略。

研究设计与样本

  • 多中心回顾性队列研究,使用日本两个全国性登记库(J-CANVAS为推导队列;JPVAS为验证队列)。
  • 对源自伯明翰血管炎活动性评分(BVAS)及额外临床相关表现的高维器官受累数据应用集成聚类。
  • 使用分类与回归树(CART)在推导和验证队列中复制所得聚类。

主要发现

  • 在726例新诊断MPA或GPA患者中,集成聚类识别出四种可重复的临床表型:无ILD的肾脏主导型、伴ILD的肾脏主导型、全身多器官型和耳鼻喉(ENT)主导型。
  • CART以良好的一致性复制了这些聚类。
  • 各聚类间的总生存和复发发生率存在差异。
  • ENT主导型表型显示有利的生存但较高的复发风险,且与CYC相比,利妥昔单抗显示出改善无复发生存的趋势,即使在MPO-ANCA阳性患者中亦然。

关键数值与推荐

  • 共纳入726例新诊断MPA或GPA患者。
  • 识别出四种可重复的临床表型:无ILD的肾脏主导型、伴ILD的肾脏主导型、全身多器官型和ENT主导型。
  • ENT主导型表型显示有利生存但较高复发风险,利妥昔单抗较CYC显示改善无复发生存的趋势。

临床怎么用

  • 基于器官受累模式的表型分类可用于AAV的风险分层。
  • ENT主导型表型患者需关注较高复发风险,利妥昔单抗可能为改善无复发生存的选项。
  • 将表型模式与ANCA血清型整合可能支持更个体化的管理策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Clinical heterogeneity in ANCA-associated vasculitis (AAV) is not fully captured by conventional disease subtypes or ANCA serotypes. We aimed to identify data-driven, clinically meaningful disease phenotypes based on patterns of organ involvement in microscopic polyangiitis (MPA) and granulomatosis with polyangiitis (GPA), and to evaluate their prognostic and therapeutic implications. METHODS: We conducted a multicentre retrospective cohort study using two nationwide Japanese registries (J-CANVAS as derivation; JPVAS as validation). Ensemble clustering was applied to high-dimensional organ involvement data derived from the Birmingham Vasculitis Activity Score and additional clinically relevant manifestations. The resulting clusters were replicated using classification and regression tree (CART) across the derivation and validation cohorts, and associations between cluster memberships and clinical outcomes (overall survival and relapse), as well as response to induction therapy, were evaluated. RESULTS: Among 726 patients with newly diagnosed MPA or GPA, ensemble clustering identified four reproducible clinical phenotypes: (a) renal-dominant without interstitial lung disease (ILD); (b) renal-dominant with ILD; (c) systemic multi-organ and (d) ear, nose and throat (ENT)-dominant. CART reproduced these clusters with good concordance. Overall survival and relapse incidence differed across clusters. The ENT-dominant cluster demonstrated favourable survival but a higher relapse risk and showed a trend towards improved relapse-free survival with rituximab compared with CYC, even among MPO-ANCA-positive patients. CONCLUSION: Organ involvement-based ensemble clustering identifies clinically meaningful and reproducible AAV phenotypes with distinct prognostic and therapeutic profiles. Integrating phenotypic patterns with ANCA serotype may enhance risk stratification and support more individualized management strategies in AAV.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Inoue H, Kida T, Fujioka K, et al. Clinical phenotypes of ANCA-associated vasculitis using ensemble clustering: prognostic and therapeutic insights from two Japanese cohorts. Rheumatology (Oxford). 2026. PMID: 42752545. doi:10.1093/rheumatology/keag483

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。